Median approval times for class III medical devices have been well above statutory deadlines set for FDA and CMS
10.1377/hlthaff.2010.1198
Saved in:
Main Authors: | Zinn, A.M., Allen, J.C., Hacker, C.S. |
---|---|
Other Authors: | DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE |
Format: | Article |
Published: |
2016
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/124654 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Utilisation review of clopidogrel: Are they used under the FDA-approved indications?
by: Surachet Niruntraporn, et al.
Published: (2018) -
New medical devices: The authors reply
by: Zinn, A.M., et al.
Published: (2016) -
Anti-ageing effects of FDA-approved medicines: a focused review
by: Thanapairoje K.
Published: (2023) -
rFC- the FDA approved endotoxin test: Discovery, Innovations & Applications
by: Ding, Jeak Ling
Published: (2021) -
Have you been drinking?
by: Chan, Grace Ying Xuan
Published: (2015)